Nifurtoinol: Difference between revisions
No edit summary |
m Protected "Nifurtoinol": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 16:48, 20 August 2015
{{drugbox
| IUPAC_name = 3-(hydroxymethyl)-1-{[(1E)-(5-nitro-2-furyl)
methylene]amino}imidazolidine-2,4-dione
| image = Nifurtoinol.png
| CAS_number = 1088-92-2
| ATC_prefix = J01
| ATC_suffix = XE02
| PubChem = 9571062
| DrugBank =
| C=9|H=8|N=4|O=6
| molecular_weight = 268.183 g/mol
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion = Renal (40–50% within the first 12 hours)
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category=
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration = Oral
}}
WikiDoc Resources for Nifurtoinol |
Articles |
---|
Most recent articles on Nifurtoinol Most cited articles on Nifurtoinol |
Media |
Powerpoint slides on Nifurtoinol |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Nifurtoinol at Clinical Trials.gov Clinical Trials on Nifurtoinol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Nifurtoinol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Nifurtoinol Discussion groups on Nifurtoinol Patient Handouts on Nifurtoinol Directions to Hospitals Treating Nifurtoinol Risk calculators and risk factors for Nifurtoinol
|
Healthcare Provider Resources |
Causes & Risk Factors for Nifurtoinol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Nifurtoinol (rINN, trade name Urfadyn) is a nitrofuran-derivative antibiotic used in the treatment of urinary tract infections.